Largest Hong Kong (HSI) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Feb 27, 2024

Discover large cap Hong Kong Pharmaceuticals & Biotech companies that are on the HSI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

99 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
2269WuXi Biologics (Cayman)HK$18.462.0%-68.3%HK$78.9bHK$51.42PE17.1xE17.5%n/a
3692Hansoh Pharmaceutical GroupHK$13.34-0.6%-10.2%HK$78.9bHK$16.70PE28.2xE11.9%1.0%
1093CSPC Pharmaceutical GroupHK$6.10-2.7%-28.9%HK$75.5bHK$9.39PE10.9xE1.4%4.5%
1801Innovent BiologicsHK$42.055.8%3.7%HK$68.5bHK$55.17PS12.5xE50.3%n/a
1177Sino BiopharmaceuticalHK$3.06-2.5%-26.4%HK$57.8bHK$5.06PE27.5xE14.3%2.6%
9926AkesoHK$47.006.3%13.3%HK$39.7bHK$56.07PE18.3xE1.4%n/a
1548Genscript BiotechHK$15.9610.2%-29.8%HK$34.3bHK$30.56PS6.1xE62.4%0%
3320China Resources Pharmaceutical GroupHK$5.23-2.1%-20.0%HK$33.3bHK$7.72PE7.9xE13.8%3.1%
867China Medical System HoldingsHK$12.64-0.6%-0.5%HK$31.2bHK$18.23PE8.4xE8.6%4.8%
1877Shanghai Junshi BiosciencesHK$12.24-1.4%-61.4%HK$29.0bHK$33.08PS7.2xE44.1%n/a
6990Sichuan Kelun-Biotech BiopharmaceuticalHK$110.908.9%n/aHK$24.3bHK$122.30PS14.9xE17.2%n/a
9995RemeGenHK$22.558.2%-58.6%HK$23.1bHK$53.23PS10.3xE67.8%n/a
570China Traditional Chinese Medicine HoldingsHK$4.3225.9%3.6%HK$21.8bHK$4.53PE21.5xE23.5%1.1%
2268WuXi XDC CaymanHK$18.22-1.7%n/aHK$21.7bHK$40.19PE84.2xE35.0%n/a
6826Shanghai Haohai Biological TechnologyHK$36.20-2.0%-12.8%HK$16.6bHK$70.01PE13.3xE22.4%1.2%
3933United Laboratories International HoldingsHK$8.344.3%73.4%HK$15.3bHK$11.37PE6.2xE-0.7%4.1%
2096Simcere Pharmaceutical GroupHK$5.43-1.6%-47.0%HK$14.7bHK$10.37PE4.1xE-29.1%3.2%
2005SSY GroupHK$4.463.2%-6.7%HK$13.2bHK$5.99PE11.1xE20.4%3.4%
512Grand Pharmaceutical GroupHK$3.661.1%-20.4%HK$13.1bn/aPE5.4xE8.7%3.8%
15303SBioHK$5.18-5.0%-35.5%HK$13.0bHK$8.43PE5.9xE7.5%1.8%
2186Luye Pharma GroupHK$2.885.5%-22.0%HK$10.8bHK$3.44PE21.8xE15.3%n/a
9969InnoCare PharmaHK$5.13-1.7%-43.1%HK$10.5bHK$10.57PS11.5xE19.9%n/a
719Shandong Xinhua PharmaceuticalHK$5.43-0.5%-29.5%HK$10.4bn/aPE6.7xn/a4.0%
2162Keymed BiosciencesHK$35.507.7%-46.7%HK$10.0bHK$75.27PS27.6xE-19.6%n/a
Page 1 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.